1. |
Surks MI, OrtizE, Daniels GH, et al.Subclinical thyroid disease:scientific review and guide lines for diagnosis and management.JAMA, 2004, 291(2):228-238.
|
2. |
Beyhan Z, Ertrk K, Ukaya G, et al.Restoration of euthyroidism does not improve cardiovascular risk factors in patients with subclinical hypothyroidism in the short term.J Endocrinal Invest, 2006, 29(6):505-510.
|
3. |
Owen PJ, Lazarus JH.Subclinical hypothyroidism:the case for treatment.Trends Endocrinol Metab, 2003, 14(2):257-261.
|
4. |
Duntas LH, Wartofsky L.Cardiovascular risk and subclinical hypothyroidism:focus on lipids and new emerging risk factors.What is the evidence?Thyroid, 2007, 17(11):1075-1084.
|
5. |
中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议.中华糖尿病杂志, 2004, 12(3):156-161.
|
6. |
史轶繁.协和内分泌和代谢学.第2版.科学出版社, 2000:1012.
|
7. |
滕卫平.开展亚临床甲状腺功能减退症的临床研究.中华内分泌代谢杂志, 2004, 20(2):93-95.
|
8. |
王佳妮, 单忠艳, 滕卫平, 等.血清促甲状腺激素与代谢综合征及其组分的相关关系研究.中国实用内科杂志, 2010, 30(6):534-536.
|
9. |
Roos A, Bakker SJ, Links TP, et al.Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.J Clin Endocrinol Metab, 2007, 92(2):491-496.
|
10. |
Duntas LH.Thyroid disease and lipids.Thyroid, 2002, 12(2):287-293.
|
11. |
Walsh JP, Bremner AP, Bulsara MK, et al.Thyroid dysfunction and serum lipids:a community-based study.Clin Endocrinol (Oxf), 2005, 63(6):670-675.
|
12. |
王微波, 金迎, 滕卫平.不同碘摄入量地区正常人群血清TSH水平的流行病学对比研究.中华内分泌代谢杂志, 2002, 18(3):355-356.
|
13. |
Bandyopadhyay SK, Basu AK, Pal SK, et al.A study on dyslipidaemia in subclinical hypothyroidism.J Indian Med Assoc, 2006, 104(11):622-626.
|
14. |
Saravanan P, Dayan CM.Thyroid autoantibodies.Endocrinnol Metab North Am, 2001, 30(3):315-338.
|
15. |
Milionis HJ, Efstathiadou Z, Tselepis AD, et al.Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism:effect of treatment with levothyroxine.Thyroid, 2003, 13(3):365-369.
|
16. |
Duggal J, Singh S, Barsano CP, et al.Cardiovascular risk with subclinical hyperthyroidism and hypothyroidism:pathophysiology and management.J Cardiometab Syndr, 2007, 2(3):198-206.
|
17. |
Prisant LM, Gujral JS, Mulloy AL.Hyperthyroidism:a secondary cause of isolated systolic hypertension.J Clin Hypertens, 2006, 8(3):596-599.
|
18. |
蔡云飞, 时景璞.亚临床甲状腺功能减退与收缩压水平的关系.中华流行病学杂志, 2011, 32(1):55-59.
|
19. |
Velkoska NV, Krstevska B, Bosevski M, et al.Dyslipidaemia and hypertension in patients with subclinical hypothyroidism.Prilozi, 2009, 30(2):93-102.
|
20. |
Luboshitzky R, Aviv A, Herer P, et al.Risk factors for cardiovascular disease in women with subclinical hypothyroidism.Thyroid, 2002, 12(5):421-425.
|
21. |
Ferreira MM, Teixeira PF, Mansur VA, et al.Ambulatory blood pressure monitoring in normotensive patients with subclinical hypothyroidism.Arq Bras Cardiol, 2010, 94(6):806-812.
|
22. |
Waterhouse DF, Walsh CD, Sheehan F, et al.An examination of the relationship between normal range thyrotropin and cardiovascular risk parameters:a study in healthy women.Thyroid, 2007, 17(3):243-248.
|
23. |
VondraK, Vrbikova J, Dvorakova K.Thyroid gland disease in adult patients with diabetes mellitus.Minerva Endocrinol, 2005, 30(4):217.
|
24. |
Chen H, Wu T, Jap T, et al.Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients.Diabetic Med, 2007, 24(12):1336-1344.
|
25. |
刘建英, 章燕, 陈国兰, 等.亚临床甲状腺功能减退与代谢综合征和糖尿病的相关性研究进展.临床荟萃, 2010, 25(5):449-451.
|